Friday, June 12, 2026

Patent directory Β· USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,769
Drugs linked 4,797

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code β€” or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 1127 of 1,261
  1. AU 2002257817

    Pharmaceutical composition comprising a lipase inhibitor and a sucrose fatty acid ester

    CHEPLAPHARM ARZNEIMITTEL GMBH [DE] Β· Granted Aug 18, 2005 Β· Expires Aug 13, 2025

    expired
  2. AU 2002319189

    Pharmaceutical compositions comprising orlistat and fatty acids and/or salts thereof

    CHEPLAPHARM ARZNEIMITTEL GMBH [DE] Β· Granted Aug 18, 2005 Β· Expires Aug 13, 2025

    expired
  3. DE 102004006048

    Pharmazeutische Kombination aus Gadolinium Komplexen und kolloidalen Biopolymeren und deren Verwendung als kontrastverstΓ€rkendes Mittel zur i.v. Injektion bzw. i.v. Infusion in der MR Angiographie

    NEUROBIOTEC GMBH [DE] Β· Granted Aug 18, 2005 Β· Expires Aug 13, 2025

    expired
  4. US 6930116

    Gyrase inhibitors and uses thereof

    Vertex Pharmaceuticals Incorporated Β· Granted Aug 16, 2005 Β· Expires Aug 11, 2025

    expired
  5. US 6929802

    Method of cancer treatment

    The Board of Regents of the University of Texas System Β· Granted Aug 16, 2005 Β· Expires Aug 11, 2025

    expired
  6. US 6930104

    Heterocyclic derivatives

    Takeda Chemical Industries Ltd. Β· Granted Aug 16, 2005 Β· Expires Aug 11, 2025

    expired
  7. US 6929799

    D-alanine racemase mutants of mycobacteria and uses therefore

    BOARD OF REGENTS UNIVERSITY OF NEBRASKA-LINCOLN Β· Granted Aug 16, 2005 Β· Expires Aug 11, 2025

    expired
  8. US 6930185

    Melanin-concentrating hormone antagonist

    Takeda Chemical Industries Ltd. Β· Granted Aug 16, 2005 Β· Expires Aug 11, 2025

    expired
  9. US 6930186

    Process for the preparation of paroxetine substantially free of alkoxy impurities

    TEVA PHARMACEUTICAL INDUSTRIES, LTD. Β· Granted Aug 16, 2005 Β· Expires Aug 11, 2025

    expired
  10. US 6930176

    Major neutralization site of hepatitis E virus and use of this neutralization site in methods of vaccination and in methods of screening for neutralizing antibodies to hepatitis E virus

    The United States of America as Represented by the Secretary of the Department of Health and Human Services Β· Granted Aug 16, 2005 Β· Expires Aug 11, 2025

    expired
  11. US 6930101

    Thiazolopyrimidines useful as TNFΞ± inhibitors

    The Regents of the University of California Β· Granted Aug 16, 2005 Β· Expires Aug 11, 2025

    expired
  12. US 6929811

    Monoamine oxidase (MAO) inhibitors and uses thereof

    Regent Court Technologies, LLC Β· Granted Aug 16, 2005 Β· Expires Aug 11, 2025

    expired
  13. US 6930084

    Treating arthritis with TNF receptor releasing enzyme

    The Regents of the University of California Β· Granted Aug 16, 2005 Β· Expires Aug 11, 2025

    expired
  14. US 6929937

    Human transferase proteins and polynucleotides encoding the same

    Lexicon Genetics, Inc. Β· Granted Aug 16, 2005 Β· Expires Aug 11, 2025

    expired
  15. US 6929910

    Diagnostic and therapeutic methods using the H37 tumor suppressor gene

    The Regents of the University of California Β· Granted Aug 16, 2005 Β· Expires Aug 11, 2025

    expired
  16. US 6929796

    Methods to treat undesirable immune responses

    Regents of the University of Minnesota Β· Granted Aug 16, 2005 Β· Expires Aug 11, 2025

    expired
  17. US 6930085

    G-type peptides to ameliorate atherosclerosis

    The Regents of the University of California Β· Granted Aug 16, 2005 Β· Expires Aug 11, 2025

    expired
  18. US 6928315

    Apparatus for impedance imaging coupled with another modality

    Mirabel Medical Systems Ltd. Β· Granted Aug 9, 2005 Β· Expires Aug 4, 2025

    expired
  19. US 6927044

    IL-1 receptor based cytokine traps

    REGENERON PHARMACEUTICALS, INC. Β· Granted Aug 9, 2005 Β· Expires Aug 4, 2025

    expired
  20. US 6927285

    Genes for human telomerase reverse transcriptase and telomerase variants

    The Regents of the University of Technology Office of Technology Transfer Β· Granted Aug 9, 2005 Β· Expires Aug 4, 2025

    expired
  21. US 6926909

    Chrono delivery formulations and method of use thereof

    Elite Laboratories, Inc. Β· Granted Aug 9, 2005 Β· Expires Aug 4, 2025

    expired
  22. AU 2005207635

    Therapeutic methods and pharmaceutical compositions for treating warts with tellurium compounds

    BIOMAS LTD [IT] Β· Granted Aug 4, 2005 Β· Expires Jul 30, 2025

    expired
  23. US 6924362

    Monoclonal antibodies specific for the E2 glycoprotein of hepatitic C virus and their use in the diagnosis, treatment, and prevention of hepatitis C

    The United States of America, as represented by the Department of Health and Human Services Β· Granted Aug 2, 2005 Β· Expires Jul 28, 2025

    expired
  24. US 6923974

    Flaky fine powder, production thereof, and cosmetic

    CATALYSTS & CHEMICALS INDUSTRIES CO., LTD. Β· Granted Aug 2, 2005 Β· Expires Jul 28, 2025

    expired

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search β€” best for looking up a specific filing or applicant portfolio slice.